LFB SA

LFB is a pharmaceutical company, the first French company in the biotech field, the fifth largest pharmaceutical company in plasma-derived medicinal products, and the third laboratory supplying drugs to hospitals in France. LFB commercializes a wide range of 19 plasma-derived medicinal products addressing more than 80 pathologies in three therapeutic fields: Immunology, Homeostasis, and Intensive Care. Each year in France, 500,000 patients are treated with LFB's products for chronic pathologies or for emergency cases. In the biotechnology field, LFB develops monoclonal antibodies and a line of therapeutic proteins through transgenic technology with GTC Therapeutics.